131 related articles for article (PubMed ID: 3125986)
21. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
Mulé JJ; Yang J; Shu S; Rosenberg SA
J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
[TBL] [Abstract][Full Text] [Related]
22. Cultured Lyt-2- L3T4- T lymphocytes from normal thymus or lpr mice express a broad spectrum of cytolytic activity.
Budd RC; Cerottini JC; MacDonald HR
J Immunol; 1986 Dec; 137(12):3734-41. PubMed ID: 3491147
[TBL] [Abstract][Full Text] [Related]
23. Expansion of large granular lymphocytes in IL-2-driven 14-day-old fetal thymocytes in organ culture.
Plum J; Koning F; Leclercq G; Tison B; De Smedt M
J Immunol; 1990 May; 144(10):3710-7. PubMed ID: 1970591
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of mouse thymocyte-derived, interleukin 2-activated killer cells and their precursors.
Yagi H; Nishimura T; Hashimoto Y
Jpn J Cancer Res; 1987 Jul; 78(7):721-8. PubMed ID: 3114198
[TBL] [Abstract][Full Text] [Related]
25. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.
Giovarelli M; Santoni A; Jemma C; Musso T; Giuffrida AM; Cavallo G; Landolfo S; Forni G
J Immunol; 1988 Oct; 141(8):2831-6. PubMed ID: 3139768
[TBL] [Abstract][Full Text] [Related]
26. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.
Clark DA; Chaput A; Walker C; Rosenthal KL
J Immunol; 1985 Mar; 134(3):1659-64. PubMed ID: 3871455
[TBL] [Abstract][Full Text] [Related]
27. Generation of lymphokine-activated killer cell activity from human thymocytes.
Ramsdell FJ; Golub SH
J Immunol; 1987 Sep; 139(5):1446-53. PubMed ID: 2442246
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
29. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
Shitara K; Ichimura O; Mitsuno T; Osawa T
J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic heterogeneity of antisyngeneic tumor killer cells (ASTK) generated in allogeneic mixed lymphocyte reactions.
Macphail S; Paciucci PA; Stutman O
J Immunol; 1984 Jun; 132(6):3205-10. PubMed ID: 6144708
[TBL] [Abstract][Full Text] [Related]
31. Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease.
Onoe Y; Harada M; Tamada K; Abe K; Li T; Tada H; Nomoto K
Immunology; 1998 Oct; 95(2):248-56. PubMed ID: 9824483
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the cytotoxic function of the thymocytes generated in a 14-day old mouse fetal thymus organ culture with high dose of IL-2.
Leclercq G; de Smedt M; Tison B; Plum J
Thymus; 1989; 13(1-2):95-102. PubMed ID: 2516374
[TBL] [Abstract][Full Text] [Related]
33. Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/- precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture.
Plum J; De Smedt M; Leclercq G
J Immunol; 1993 Apr; 150(7):2706-16. PubMed ID: 8095954
[TBL] [Abstract][Full Text] [Related]
34. Induction of lymphokine-activated killer cells from rat thymocytes using recombinant human interleukin-2.
Imaya H; Matsuura H; Kudo M; Nakazawa S
Cancer Immunol Immunother; 1988; 27(1):13-6. PubMed ID: 3260819
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic and functional properties of murine thymocytes. I. Precursors of cytolytic T lymphocytes and interleukin 2-producing cells are all contained within a subpopulation of "mature" thymocytes as analyzed by monoclonal antibodies and flow microfluorometry.
Ceredig R; Glasebrook AL; MacDonald HR
J Exp Med; 1982 Feb; 155(2):358-79. PubMed ID: 6120202
[TBL] [Abstract][Full Text] [Related]
36. Tolerogenic ability of thymocytes in organ-cultured thymus lobes.
Matsuhashi N; Kawase Y; Suzuki G
J Immunol; 1991 Jan; 146(2):444-8. PubMed ID: 1670942
[TBL] [Abstract][Full Text] [Related]
37. Generation of cytotoxic T lymphocytes from thymocyte precursors to trinitrophenyl-modified self antigens. I. Requirement of both killer-helper factor(s) and interleukin 2 for CTL generation from a subpopulation of thymocytes.
Takatsu K; Kikuchi Y; Kanatani T; Okuno K; Hamaoka T; Tominaga A; Sano Y
J Immunol; 1986 Feb; 136(4):1161-70. PubMed ID: 3080519
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity.
Aoki T; Kikuchi H; Miyatake S; Oda Y; Iwasaki K; Yamasaki T; Kinashi T; Honjo T
J Exp Med; 1989 Aug; 170(2):583-8. PubMed ID: 2787831
[TBL] [Abstract][Full Text] [Related]
40. Resting human peripheral blood lymphocytes can be activated to cytolytic function by antibodies to CD3 in the absence of exogenous interleukin-2.
Scott CF; Lambert JM; Bolender S; Blattler WA
Cell Immunol; 1988 Jul; 114(2):370-84. PubMed ID: 3260543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
